文献速递肝胆胰外科围术期管理与 ERAS

体质指数分层下腹腔镜与机器人胆囊切除术使用趋势及结局

Trends in Use and Outcomes of Laparoscopic vs Robotic Cholecystectomy Based on BMI: A Statewide Analysis.
PubMed 文献 · J Am Coll Surg · 2026-04-16

基于全州69家医院临床登记数据,分析2020至2024年27,006例择期腹腔镜(68.9%)或机器人(31.1%)胆囊切除术患者,按BMI分层比较结局。机器人途径随时间增加,BMI≥50 kg/m2组增幅最大;BMI未改变手术途径与术后并发症风险的关系。

要点

  • 择期微创胆囊切除术中机器人途径使用率逐年上升,BMI≥50 kg/m2患者增幅最大。
  • 高BMI与机器人途径选择相关,但BMI未显著改变手术途径对术后并发症风险的影响。
  • 研究未显示机器人较腹腔镜在术后结局上存在BMI分层差异。

核心结论

  • 机器人途径在择期微创胆囊切除术中应用增加,尤其在高BMI患者中;各BMI组间机器人与腹腔镜术后结局无差异,BMI未改变手术途径与结局的关系。

研究设计与样本

  • 全州69家医院成员临床登记数据分析,纳入2020至2024年择期机器人或腹腔镜胆囊切除术患者,按BMI(<35、35–49.9、≥50 kg/m2)分层,采用多变量logistic回归及交互项分析。

主要发现

  • 共27,006例患者接受腹腔镜(18,610;68.9%)或机器人(8,396;31.1%)胆囊切除术。
  • 机器人途径随时间增加,BMI≥50 kg/m2组从2020年23.1%增至2024年55.8%(p<0.001)。
  • 机器人手术患者更可能BMI较高(35–49.9 kg/m2:OR 1.15,95%CI 1.08–1.23,p<0.001;≥50 kg/m2:OR 1.34,95%CI 1.14–1.57,p<0.001)。
  • BMI未改变手术途径对术后并发症风险的影响(35–49.9 kg/m2机器人:OR 0.97,95%CI 0.60–1.56,p=0.887;≥50 kg/m2机器人:OR 1.55,95%CI 0.50–4.86,p=0.451)。

临床怎么用

  • 在高BMI患者择期微创胆囊切除术中,机器人途径使用增加,但现有结局数据未支持其较腹腔镜改善术后并发症风险。
  • 临床决策可结合机器人可及性与患者BMI选择途径,不应仅基于BMI认为机器人必然降低并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic surgery may mitigate technical challenges associated with patient obesity. However, prevalence of robotic cholecystectomy and impact on outcomes in patients with obesity are unclear. We evaluated trends in robotic cholecystectomy, factors contributing to robot use, and outcomes based on BMI. STUDY DESIGN: We analyzed data from a statewide, 69-hospital member clinical registry and identified patients who underwent elective robotic or laparoscopic cholecystectomy from 2020 to 2024. Patients were stratified by BMI (lower than 35 kg/m2, 35 to 49.9 kg/m2, greater than or equal to 50 kg/m2) and outcomes were compared. Multivariable logistic regression was used to evaluate the association between patient characteristics, surgical approach, and outcomes. An interaction term was used to evaluate the impact of BMI category on the risk associated with the surgical approach. RESULTS: A total of 27,006 patients underwent laparoscopic (18,610; 68.9%) or robotic (8,396; 31.1%) cholecystectomy. Robotic approach increased over time, with the greatest increase in patients with BMI greater than or equal to 50 kg/m2 (23.1% in 2020 vs 55.8% in 2024, p < 0.001). Compared with patients who underwent laparoscopic surgery, those who underwent robotic surgery were more likely to have a higher BMI (BMI 35 to 49.9 kg/m2: odds ratio [OR] 1.15, 95% CI 1.08 to 1.23, p < 0.001; BMI greater than equal to 50 kg/m2: OR 1.34, 95% CI 1.14 to 1.57, p < 0.001). BMI did not modify the effect of surgical approach on postoperative complication risk (BMI 35 to 49.9 kg/m2 with robotic approach: OR 0.97, 95% CI 0.60 to 1.56, p = 0.887; BMI greater than or equal to 50 kg/m2 with robotic approach OR 1.55, 95% CI 0.50 to 4.86, p = 0.451). CONCLUSIONS: Robotic approach is increasingly used in elective minimally invasive cholecystectomy, especially for patients with the highest BMI. Postoperative outcomes did not differ across BMI groups between robotic and laparoscopic cholecystectomy, indicating that BMI did not alter the relationship between surgical approach and outcomes.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. VanWinkle CK, Howard R, Sow MK, et al. Trends in Use and Outcomes of Laparoscopic vs Robotic Cholecystectomy Based on BMI: A Statewide Analysis. J Am Coll Surg. 2026. PMID: 41989288. doi:10.1097/XCS.0000000000001713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。